call by in team us year everyone. you place, joining and today. closing spending, management we more strategic margins reduced our year-over-year and and XXXX. new off burn a then with core posted XXXX. cash good We which Thank the the quarter in you, from on growth and start and fourth solid lowered afternoon, transaction A are to Peter, significantly to of a products than after We XX% service appreciate revenues the
committed We are running strategy. through diversified our the scale-building next industry-leading and science company execution operational playbook and life tools to building are
culture committed or Business BioTools is SBS want to early, for I organization Standard for focus behind a all to our lean but entire and results. based these short. on The encouraging Systems their dedication, execution employees recognize
culture become BioTools firmly is we lean Standard the has common allow believe organization. embraced Our our a and SBS, to denominator, team will high-performance fully which
XX we against we In priorities our ago. review the one outlined year progress the helm first-order company past months, of made the just tangible the two and when quarter took over of
it to to the The and discipline towards pushing drive stabilize second and business the to back and core improve operating first business, was this growth. profitability; increase rationalize to was productivity
a we With infrastructure these our growth. the expand leverage third, that acquiring product indicated goals, and our two offerings assets by operating complementary accelerate
I context will priorities headed. for call look call more performance. During financial financial strategic where provide quarter Vikram turn and summary first to our our the these operational of the I'll a three business the discuss highlights the in and a today, at of performance over is detailed
improving spending processes. business and efficiency since $XX.X in and $X.X one first $XX.X million, progress operating our We worked Let's of manufacturing the across for the was that the million quarter cash to and below fourth down internal in million day hard center sales quality and Net the fundamental our have was in an front operating profitability, also quarter while and our begin and is which the board consumed first to thesis. towards by overbuilt discussing the used XXXX. significantly to budget the burned quarter G&A in inherited improve activities inefficient execution,
some moved with of year, as last as executed was real also our restructuring a realigned This in estate European residual the reductions included organization. we consolidation sales quarter, first this footprint, our of Most discussed, for are of for previously Francisco our Ontario South operations consolidations. have footprint subleased some total our opportunities a looking as Markham, San further now to and facilities. of XX% We
pleased are we we with progress and While are this means no we done. where by are headed,
us Our Kaizen-based are approach it. that improvement. can more getting commits and to There's continuous done, after relentlessly we always be
core year best benefits a and primarily margins, sales revenue ago. moving you target to with quarter The Next, service core, to reached margins stable better driven margin in believe to place fourth was at our moderate started. XX.X%, build mix, in a much some Today, a the tangible need $XX.X $XX.X of where of a came The at quarter was sign XX% stronger product of stability these signals the million growth. part increase we compared product and million and and we the leading service and towards products that product we of initiatives. lean delivered than XX%. a company, Core pricing was manufacturing discipline by non-GAAP our
And as cash compared million our was fourth $XXX.X at end of the $XX.X in the in million first in million balance to mentioned, quarter, quarter quarter. burn the of I the resulting just operating $X.X a cash
in think categories: can One our instruments, of consumables and business three services.
installed consumables portfolio sticky customers service a drive and recurring high-margin is right enable high-quality, and of strategy science the revenues. instruments will when Our with to great margins, higher have that,
growing from extension, and revenue services, With revenue customer is revenue recurring instrument drive high sources. a service to high-margin is look year the will are high-value in levels increased for component following when over subsequent recurring the by businesses, key both the were of of quarter consumables This in XX% fully revenue our running. where of up and our we core these we and years. instruments recurring If our revenues first respect product successful
a mind, current two more With to lines. that in would on bit color I provide business like the
are currently which and wage field than instrument in pull-through approximately There in path quarter. healthy growth, XXX to the the more Proteomics $XX,XXX per up and units the our business, per in in First, year-over-year average is first year. margins XX% on with increase
in drive placements, approaches year, fluorescent Meeting. six takes faster last that Xx protein the more for cyclic we is few Hyperion with launching papers of resolution, scan month's than walk-up improved at products, with legacy Hyperion days to digital-like American workflow a peer-reviewed imaging The expected user approaches Annual XTi To XTi than slides auto-fluorescence, our XX of per to has contrast become an standard day spatial the system quickly for including markers. typically XTi lack also Research for The experience, and XX are and of Association our instrument first launch Cancer new at the new a that slides.
product which that the and pull-through the mouse increases on as panel, further another our line technology mouse launched immune end-to-end We preclinical also research, profiling XX-marker our utility instruments, standard these in and to heading drive will to compare We expanding believe solution flow a exciting inherently our to fluorescent-based immune advantages we fluorescent-based spectral our meeting And quantify and the over flow. this technology are are this point, over approaches. advantaged excited capabilities in we CYTO Montreal later to showcase the and is cytometry month, where profiling.
to Genomics Turning business. our
with is of line current are for started, Performance as As in it this headcount. our reduction product we line expectations on rationalization such, our focused more acknowledged and, after mature profitability. for business running and we the we was platform our when
and a basis, in emphasizes now While wage our expect accounts, quarter, non-GAAP in go-to-market OEM the this strategy and first translated a to and maximize into XX% of key positive a partnerships the pull-through. placement on we year-over-year decline ramp
accelerate and us smart In to instruments, way, prudent This doing the leverage infrastructure growth reagents scale, to importantly, can adding leads inorganic through most our so priority, and our profitability. in sheet growth. third and, and our and balance services we
Our and profitable are many been thesis is technologies, that companies but have few there that to able businesses. innovative scale build great
our Standard a in potentially strategy, about macro uniquely know with consolidation where to the especially environment, that excited I chassis our our positioned, and central We to are believe with you BioTools that attractive a we us founders provides a well to value to proposition current impact. is for well they consolidate. excited all. is our joining share know tuned. resonates mission. We for and work I'm reiterate Such we journey can this want Stay meaningful have company and shareholders,
for I of to review will Vikram Vikram? financial results. now turn it a our over
